CHINUCLIDINDERIVAT

European patent · EP3266777 · In force

Register entry

Publication number
EP3266777
Application number
EP16758830
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 25, 2016
Published
Jan 10, 2018
Granted
May 5, 2021
Protection ends at the latest
Feb 24, 2036
Next annual fee due
Feb 28, 2027
IPC classes
C07D 453/02 (2006.01)
A61K 31/439 (2006.01)
A61P 11/00 (2006.01)
A61P 43/00 (2006.01)
Priority
JP 2015040321 02.03.2015
PCT application
PCT/JP2016/055637 25.02.2016
PCT publication
WO2016/140136 09.09.2016
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Mar 16, 2022

    Change

    Published in Swissreg on 16.03.2022

  6. May 5, 2021

    Granted

    Published in Swissreg on 05.05.2021

Parties

Holder

LTT Bio- Pharma Co., Ltd.

LTT Bio-Pharma Co., Ltd.

2-20, Kaigan 1-chome, Minato-ku Tokyo 105-0022, JP

Inventor

YAMAKAWA, Naoki

Okayama-shi Okayama 700-0011, JP

YAMASHITA, Yasunobu

Tokyo 105-0022, JP

MIZUSHIMA, Tohru

Tokyo 105-0022, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.